Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions.
Explore this paper's citation graph
Summary
Periprocedural major bleeding occurs relatively frequently and is associated with adverse outcomes, and patients >80 years of age who experience intraprocedural complications are at particularly high risk.
- Type
- article
- Published
- 2003-10-15
- Cited by
- 579
- References
- 28
- OpenAlex
- https://openalex.org/W1979372622
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:42656196
Keywords
Medicine, Hematocrit, TIMI, Percutaneous coronary intervention, Myocardial infarction
References
- Epitope mapping: three‐dimensional insights from molecular biology
- Predictors of gastrointestinal complications in cardiac surgery.
- A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
- Association of thrombocytopenia with the use of intra-aortic balloon pumps.
- Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997.
- Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention.
- Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators.
- Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention.
- Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab.
- Trends in outcome and costs of coronary intervention in the 1990s.
- Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.
- Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
- Vascular Complications After Balloon and New Device Angioplasty
- Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators.
- Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
- Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.
- Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I).
- Bleeding risks with abciximab after full-dose thrombolysis in rescue or urgent angioplasty for acute myocardial infarction.
- Effect of anaemia and cardiovascular disease on surgical mortality and morbidity.
- Complications of diagnostic and therapeutic ERCP: a prospective multicenter study
Cited by
- Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
- The ECG as decision support in STEMI.
- Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
- A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.
- Impact of bivalirudin on outcomes after percutaneous coronary revascularization with drug-eluting stents.
- Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).
- Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction.
- Transcarpal cardiac catheterization.
- A risk score to predict bleeding in patients with acute coronary syndromes.
- Defining the Optimal Degree of Heparin Anticoagulation for Peripheral Vascular Interventions: Insight From a Large, Regional, Multicenter Registry
- Improved biological efficacy of prasugrel one month after an acute coronary syndrome.
- Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era
- Radial Artery Occlusion After Transradial Approach to Cardiac Catheterization
- Targeting the safe zone: A quality improvement project to reduce vascular access complications
- Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population
- Adverse effects of heparin.
- Retroperitoneal hematoma after percutaneous coronary intervention: prevalence, risk factors, management, outcomes, and predictors of mortality: a report from the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) registry.
- Simple risk algorithm to predict serious bleeding in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: RISK-PCI bleeding score.
- Variations in the Use of Blood Transfusion in Patients with Coronary Artery Disease
- The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions
Related papers
- Effect of tirofiban on TIMI flow in patients with STEMI during primary PCI
- Time Choice of PCI in Patients with Acute Myocardial Infarction
- The effect of intravenous thrombolysis on TIMI flow of patients with acute myocardial infarction
- Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off‐hours compared with direct primary intervention during regular hours
- [Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].
- Safety and efficacy of early versus elective percutaneous coronary intervention on patients with non-ST segment elevation infarction
- e0485 Clinic study of domestic tirofiban on TIMI Flow during facilitated PCI
- Two-Year Clinical Outcomes According to Pre-PCI TIMI Flow Grade and Reperfusion Timing in Non-STEMI After Newer-Generation Drug-Eluting Stents Implantation
- Non-achievement of TIMI-3-flow results in significant increase in hospital mortality of primary PCI for STEMI and PCI for NSTE-ACS - findings of the Euro Heart survey PCI-registry
- Clinical pattern changes in elderly patients who underwent percutaneous coronary intervention in the last ten years